Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 1999

View Archived Issues

Lundbeck and Neurochem to conduct joint AD research

Flu drug rimantadine has trypanocidal activity

Cystic Fibrosis Foundation awards research grant to Genzyme

Accelerated vaccination schedule effective for Lyme disease

Evista granted priority review for osteoporosis treatment; Lilly details strategic plans

Ares-Serono's Rebif shows promising results in three-year SPMS trial

Genentech and Immunex reach license agreement for immunoadhesin technology

ODAC recommends approval of Ethyol for dry mouth

FDA advisory committee recommends approval of Doxil sNDA

Roberts' Agrylin receives orphan drug status in Japan

Allelix's new treatment for short bowel syndrome advances to phase II

Sibia adds three new product candidates to the pipeline in 1998

Sankyo obtains rights to copromote itavastatin in Japan, exclusive R&D and marketing rights in U.S.

Sankyo teams up with Warner-Lambert to develop new antidiabetic agent

Antiischemic phenoxypyridines designed at Taisho

Novel cytotoxic compound isolated from marine tunicate at Spanish research institute

Semisynthetic macrolides under study at Abbott

Gensia Sicor will reorganize in 1999

Novel MTP inhibitors for lipid and other metabolic disorders

Pleuromutilin derivatives claimed by SB for recurrent sinusitis, otitis, etc.

New agents for IBS in development at Kyorin

Tresperimus for the treatment of GvHD in bone marrow transplant recipients

Antitumor substance produced by Aspergillus discovered at Nippon Kayaku

Ophidian in the process of expanding clinical development programs

Cipramil to be comarketed in Denmark by Nycomed

Maxamine plus IL-2 prolongs duration of complete remission in patients with AML

Dendreon moves ahead with dendritic cell therapies for cancer

Relabeling in order for Pfizer's Trovan following reports of liver toxicity; FDA advisory issued

Leflunomide's efficacy and safety in RA highlighted at EULAR congress

Vivus announces another European launch for Muse

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...